Point72 Asset Management, L.P.
Position in RLMD — Relmada Therapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in RLMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,513,547
+$2,608,517 QoQ
Shares Held
504,820
+169.4% QoQ
Ownership
0.473%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Derivatives in RLMD
reported options exposure · as of Sep 30, 2022CallValue
$2,591,400
CallShares
70,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in RLMD
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,513,547 | 504,820 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $905,030 | 187,377 | Shares | Defined | 2026-02-17 | |
| 2023-12-31 | $1,035,000 | 250,000 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $11,569 | 4,703 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $2,591,400 | 70,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $30,992,773 | 837,190 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,166,180 | 1,272,574 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $35,421,676 | 1,312,400 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,320,431 | 946,313 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,766,200 | 220,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,226,265 | 194,510 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,073,725 | 172,500 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,139,950 | 285,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,497,327 | 199,291 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $7,364,015 | 164,559 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||